ClinicalTrialsFinder

High-Risk Cancer Clinical Trials in Nanchang, None Selected

1 recruitingNanchang, None Selected, China

Showing 1–1 of 1 trials

Recruiting
Phase 3

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal CarcinomaHigh-Risk CancerMaintenance Therapy
Jiangxi Provincial Cancer Hospital264 enrolled3 locationsNCT06277050